Cancer

August 15, 2019

Shaping the landscape of cancer care with precision therapies

By Sharon Rosen sharonhrosen

Article by Sara Damore Jeffrey Tyner, Ph.D., associate professor in the Department of Cell & Developmental Biology at Oregon Health & Science University, will join several precision cancer care leaders from across the country at the annual Individualizing Medicine Conference. Dr. Tyner will present “Precision Therapy through Functional Genomics in Hematologic Malignancies.” Dr. Tyner’s research […]

View full entry

Tags: #acute myeloid leukemia, #CIMCon19, #Dr. Jeffrey Tyner, #Functional Genomics, #targeted therapies, blood cancers, center for individualized medicine, genomics, hematolgic malignancies, Individualizing Medicine Conference 2019, mayo clinic, Oregon Health and Science University


August 13, 2019

An Artificial Intelligence Tool to Improve Pancreatic Cancer Outcomes

By Sharon Rosen sharonhrosen

Article by Barbara Toman Only 9% of people with pancreatic cancer live for five years after diagnosis. “That is an abysmally low number, probably the worst in human cancers,” says Michael Wallace, M.D., a digestive disease specialist at the Mayo Clinic campus in Florida. “We want to get that rate substantially higher.” Artificial intelligence is […]

View full entry

Tags: #algorithm, #Artificial Intelligence, #Champions for Hope, #digestive diseases, #Dr. Michael Wallace, #Florida Cancer Coalition, #National Comprehensive Cancer Network, #University of Central Florida, cancer screening, center for individualized medicine, Florida Pancreas Cancer Coalition, Genetic Testing


July 25, 2019

Antoni Ribas, M.D., Ph.D. – leading melanoma researcher to speak at #CIMCON19

By Sharon Rosen sharonhrosen

Article by Sara Damore Melanoma is an aggressive skin cancer caused by extensive sun exposure and the fifth most common cancer in the U.S. If detected and treated early, the survival rates for melanoma are high (98%). However, once the cancer spreads to other areas of the body, survival rates for malignant melanoma drop dramatically […]

View full entry

Tags: #CIMCon19, #skin cancer, BRAF gene, center for individualized medicine, Dr. Antoni Ribas, geenetics, genomics, Herpes virus, immunotherapy, individualized medicine, mayo clinic, Melanoma


July 18, 2019

Targeting therapy to each patient’s unique cancer

By Sharon Rosen sharonhrosen

Article by Sara Damore As DNA sequencing technology helps bring genetic factors driving disease into focus, researchers have developed new cancer therapies to target a patient’s unique cancer, especially for those who do not respond to standard therapy. Funda Meric-Bernstam, M.D., a physician-scientist at MD Anderson Cancer Center will speak on Decision Support  for Precision […]

View full entry

Tags: #CIMCon19, #Mayo Cllinic, breast cancer, center for individualized medicine, Dr. Alan Bryce, Dr. Funda Meric-Bernstam, Genetic Sequencing, Genetic Testing, Individualizing Medicine Conference 2019, lymphoma, MD Anderson, Melanoma


July 16, 2019

Kentucky community hospital develops precision medicine program with help from Mayo Clinic

By Sharon Rosen sharonhrosen

Article by Rachel Guibert and Alyson Gonzalez When staff at St. Elizabeth Healthcare in Kentucky — a Mayo Clinic Care Network member — decided that they wanted to bring precision medicine to their patients, they turned to Mayo Clinic for help. “We’re a community hospital that doesn’t have the deep resources academically, and in order […]

View full entry

Tags: ActX, center for individualized medicine, Dr. Eric Matey, Dr. Mark Larson, genetic screening service, Genetic Testing, health care consulting, mayo clinic, Mayo Clinic Care Network, Mayo Clinic Individualizing Medicine Conference, St. Elizabeth Heathcare


July 9, 2019

Mayo experts provide insights into how genes affect medication response

By Sharon Rosen sharonhrosen

Pharmacogenomics – how a person’s genes affect medication response – is touching virtually every area of medical care.  Findings from the Mayo Clinic RIGHT study (Right Drug, Right Dose, Right Time–Using Genomic Data to Individualize Treatment) showed that 99% of participants had at least one genetic variant that may affect their response to medications.    […]

View full entry

Tags: #addiction, #anti-seizure medication, #Center for Individualized Mediicine, #Dr. Lauren Cornell, #Dr. Sanjay Bagaria, #Dr. William Freeman, #Dr. William Palmer, #drug-gene interactions, #epilepsy, #estrogen receptor positive breast cancer, #medical education, #neurological diseases


June 28, 2019

Can BioBanks Help Close Gaps in Health Outcomes?

By Barbara J. Toman barbaratoman

By definition, personalized medicine requires diversity. One-size-fits-all doesn’t work for every individual, especially members of groups that are medically underserved. In collaboration with Arizona State University and Mountain Park Health Center (MPHC) in Phoenix, Mayo Clinic’s Center for Individualized Medicine has created a biobank to enhance the diversity of Mayo’s medical research. Sangre Por Salud (Spanish for […]

View full entry

Tags: #Arizona State University, #diabetes, #disease risk, #Dr. Richard Caselli, #Giovanna Moreno Garzon, #Health Disparities, #high blood pressure, #Mayo Clinic Biobank, #Mountain Park Health Center, #obesity, #Sangre Por Salud, #underserved populations


June 3, 2019

Identifying hereditary cancer risk: genetic testing can lead to better screening, earlier treatment

By Sharon Rosen sharonhrosen

Do you have family members who have been diagnosed with gastrointestinal, breast or ovarian cancer? According to a recent Mayo Clinic study, nearly 5% to 10% of these cancers can be hereditary. That’s why it is important to share your family medical history with your physician, who can determine if you and your family members […]

View full entry

Tags: #cancer risk, #Center for Individualized Mediicine, #gastrointestinal cancer, breast cancer, colorectal cancer, Dr. Niloy "Jewel" Samadder, Genetic Testing, genomics, hereditary cancer, lynch syndrome, mayo clinic, Mayo Clinic Proceedings


May 29, 2019

Individualizing Medicine 2019 Conference – practical precision cancer care approaches for your patients

By Sharon Rosen sharonhrosen

Amidst the demands of providing care for patients with cancer, it can be challenging for oncologists and their care teams to keep up with the rapidly evolving field of genomics. Practical ways to apply the latest precision medicine discoveries is the focus of this year’s Individualizing Medicine Conference: Precision Cancer Care through Immunotherapy and Genomics, […]

View full entry

Tags: #CAR T-cell therapy, #CIMCon19, biliary cancer, breast cancer, center for individualized medicine, Dr. Alan Bryce, familial cancer syndromes, hematologic cancers, immunotherapies, Individualizing Medicine Conference 2019, Lung Cancer, lymphoma


May 7, 2019

Targeting bile duct cancer – meet Mitesh Borad, M.D.

By Sharon Rosen sharonhrosen

The search for treatment targets for patients with bile duct cancer, also known as cholangiocarcinoma, has taken a 360 degree turn, offering new hope for patients. That’s according to Mitesh Borad, M.D., deputy director for Center for Individualized Medicine Biomarker Discovery Program at Mayo Clinic’s Arizona campus, Dr. Borad and his colleagues are using new […]

View full entry

Tags: #Dr. Mitesh Borad, #liver cancer, #targeted therapies, bile duct cancer, Biomarker Discovery Program, cholangiocarcinoma, fibroblast growth factor receptor (FGFR) inhibitors, Genetic Testing, genomics, Liquid biopsy, mayo clinic, Mayo Clinic Center for Individualized Medicine


Contact Us · Privacy Policy